

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | synaptic vesicle maturation (GO:0016188) | 6.43456757 |
| 2 | regulation of short-term neuronal synaptic plasticity (GO:0048172) | 6.17344157 |
| 3 | synaptic vesicle exocytosis (GO:0016079) | 5.77032758 |
| 4 | locomotory exploration behavior (GO:0035641) | 5.69382995 |
| 5 | positive regulation of calcium ion-dependent exocytosis (GO:0045956) | 5.58181883 |
| 6 | positive regulation of excitatory postsynaptic membrane potential (GO:2000463) | 5.34319443 |
| 7 | glutamate secretion (GO:0014047) | 5.28428658 |
| 8 | regulation of synaptic vesicle exocytosis (GO:2000300) | 5.06112788 |
| 9 | synaptic vesicle docking involved in exocytosis (GO:0016081) | 4.83978092 |
| 10 | regulation of synaptic vesicle transport (GO:1902803) | 4.68155775 |
| 11 | regulation of neuronal synaptic plasticity (GO:0048168) | 4.62637083 |
| 12 | vocalization behavior (GO:0071625) | 4.60466580 |
| 13 | regulation of glutamate receptor signaling pathway (GO:1900449) | 4.59236697 |
| 14 | regulation of long-term neuronal synaptic plasticity (GO:0048169) | 4.58636798 |
| 15 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor act | 4.56324746 |
| 16 | regulation of synapse structural plasticity (GO:0051823) | 4.54022384 |
| 17 | protein localization to endosome (GO:0036010) | 4.53512492 |
| 18 | ionotropic glutamate receptor signaling pathway (GO:0035235) | 4.36530917 |
| 19 | neuronal action potential propagation (GO:0019227) | 4.34748929 |
| 20 | exploration behavior (GO:0035640) | 4.32812143 |
| 21 | neurotransmitter secretion (GO:0007269) | 4.29662412 |
| 22 | cellular potassium ion homeostasis (GO:0030007) | 4.19976892 |
| 23 | protein localization to synapse (GO:0035418) | 4.14409698 |
| 24 | L-amino acid import (GO:0043092) | 4.13243752 |
| 25 | glutamate receptor signaling pathway (GO:0007215) | 3.99141460 |
| 26 | sodium ion export (GO:0071436) | 3.93885840 |
| 27 | cytoskeletal anchoring at plasma membrane (GO:0007016) | 3.93400210 |
| 28 | regulation of N-methyl-D-aspartate selective glutamate receptor activity (GO:2000310) | 3.88208924 |
| 29 | regulation of dendritic spine morphogenesis (GO:0061001) | 3.86908965 |
| 30 | amino acid import (GO:0043090) | 3.86643721 |
| 31 | regulation of synaptic plasticity (GO:0048167) | 3.84313811 |
| 32 | synaptic transmission, glutamatergic (GO:0035249) | 3.83633830 |
| 33 | layer formation in cerebral cortex (GO:0021819) | 3.82849184 |
| 34 | long-term memory (GO:0007616) | 3.80817973 |
| 35 | activation of protein kinase A activity (GO:0034199) | 3.76975139 |
| 36 | neuron-neuron synaptic transmission (GO:0007270) | 3.76352678 |
| 37 | proline transport (GO:0015824) | 3.74608267 |
| 38 | regulation of excitatory postsynaptic membrane potential (GO:0060079) | 3.74260705 |
| 39 | neuromuscular process controlling posture (GO:0050884) | 3.73827307 |
| 40 | G-protein coupled acetylcholine receptor signaling pathway (GO:0007213) | 3.65500319 |
| 41 | neuromuscular process controlling balance (GO:0050885) | 3.63464520 |
| 42 | positive regulation of membrane potential (GO:0045838) | 3.61269770 |
| 43 | long-term synaptic potentiation (GO:0060291) | 3.58085356 |
| 44 | synaptic vesicle endocytosis (GO:0048488) | 3.57749288 |
| 45 | prepulse inhibition (GO:0060134) | 3.53655897 |
| 46 | regulation of postsynaptic membrane potential (GO:0060078) | 3.48786727 |
| 47 | regulation of vesicle fusion (GO:0031338) | 3.47747848 |
| 48 | gamma-aminobutyric acid signaling pathway (GO:0007214) | 3.43926910 |
| 49 | positive regulation of synapse maturation (GO:0090129) | 3.42792914 |
| 50 | membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 3.42683117 |
| 51 | neuron cell-cell adhesion (GO:0007158) | 3.42058750 |
| 52 | positive regulation of synaptic transmission, glutamatergic (GO:0051968) | 3.41319345 |
| 53 | negative regulation of amyloid precursor protein catabolic process (GO:1902992) | 3.39237979 |
| 54 | behavioral fear response (GO:0001662) | 3.37688201 |
| 55 | behavioral defense response (GO:0002209) | 3.37688201 |
| 56 | neurotransmitter transport (GO:0006836) | 3.36188434 |
| 57 | cell communication by electrical coupling involved in cardiac conduction (GO:0086064) | 3.35348315 |
| 58 | * regulation of early endosome to late endosome transport (GO:2000641) | 3.33683465 |
| 59 | negative regulation of amino acid transport (GO:0051956) | 3.33649017 |
| 60 | regulation of glutamate secretion (GO:0014048) | 3.33388354 |
| 61 | stress fiber assembly (GO:0043149) | 3.32407727 |
| 62 | dendritic spine morphogenesis (GO:0060997) | 3.31795020 |
| 63 | regulation of synaptic transmission, glutamatergic (GO:0051966) | 3.28933985 |
| 64 | neurotransmitter-gated ion channel clustering (GO:0072578) | 3.28861300 |
| 65 | cell-substrate adherens junction assembly (GO:0007045) | 3.28627953 |
| 66 | focal adhesion assembly (GO:0048041) | 3.28627953 |
| 67 | regulation of neurotransmitter levels (GO:0001505) | 3.26892064 |
| 68 | positive regulation of synaptic transmission, dopaminergic (GO:0032226) | 3.25116330 |
| 69 | positive regulation of synaptic transmission, GABAergic (GO:0032230) | 3.24940521 |
| 70 | mating behavior (GO:0007617) | 3.24730390 |
| 71 | regulation of clathrin-mediated endocytosis (GO:2000369) | 3.23319779 |
| 72 | synaptic transmission, dopaminergic (GO:0001963) | 3.20830884 |
| 73 | response to histamine (GO:0034776) | 3.18527050 |
| 74 | positive regulation of vesicle fusion (GO:0031340) | 3.12949690 |
| 75 | adherens junction assembly (GO:0034333) | 3.12920026 |
| 76 | activation of Rac GTPase activity (GO:0032863) | 3.12783199 |
| 77 | gamma-aminobutyric acid transport (GO:0015812) | 3.11381452 |
| 78 | regulation of neurotransmitter secretion (GO:0046928) | 3.09760221 |
| 79 | behavioral response to cocaine (GO:0048148) | 3.09706983 |
| 80 | regulation of dendritic spine development (GO:0060998) | 3.08776192 |
| 81 | fear response (GO:0042596) | 3.08680317 |
| 82 | dendritic spine organization (GO:0097061) | 3.07970628 |
| 83 | long term synaptic depression (GO:0060292) | 3.07237670 |
| 84 | positive regulation of neurotransmitter transport (GO:0051590) | 3.06658884 |
| 85 | * vesicle transport along microtubule (GO:0047496) | 3.06502855 |
| 86 | cell communication by electrical coupling (GO:0010644) | 3.05955662 |
| 87 | positive regulation of neurotransmitter secretion (GO:0001956) | 3.05901079 |
| 88 | regulation of ARF protein signal transduction (GO:0032012) | 3.04056135 |
| 89 | positive regulation of synaptic transmission (GO:0050806) | 3.03386157 |
| 90 | signal complex assembly (GO:0007172) | 3.02665905 |
| 91 | cerebellar granule cell differentiation (GO:0021707) | 3.02581728 |
| 92 | regulation of neurotransmitter transport (GO:0051588) | 3.01800824 |
| 93 | cortical actin cytoskeleton organization (GO:0030866) | 3.00541757 |
| 94 | transmission of nerve impulse (GO:0019226) | 3.00440112 |
| 95 | negative regulation of erythrocyte differentiation (GO:0045647) | 2.99935675 |
| 96 | positive regulation of fibroblast migration (GO:0010763) | 2.99516729 |
| 97 | regulation of dopamine uptake involved in synaptic transmission (GO:0051584) | 2.98417872 |
| 98 | regulation of catecholamine uptake involved in synaptic transmission (GO:0051940) | 2.98417872 |
| 99 | barbed-end actin filament capping (GO:0051016) | 2.98231539 |
| 100 | regulation of synaptic transmission (GO:0050804) | 2.97560560 |
| 101 | cell-substrate junction assembly (GO:0007044) | 2.95329986 |
| 102 | regulation of voltage-gated calcium channel activity (GO:1901385) | 2.92273756 |
| 103 | positive regulation of potassium ion transmembrane transporter activity (GO:1901018) | 2.91817372 |
| 104 | regulation of inhibitory postsynaptic membrane potential (GO:0060080) | 2.91630356 |
| 105 | G-protein coupled glutamate receptor signaling pathway (GO:0007216) | 2.90285555 |
| 106 | negative regulation of toll-like receptor 4 signaling pathway (GO:0034144) | 2.89325686 |
| 107 | activation of MAPKKK activity (GO:0000185) | 2.89125990 |
| 108 | establishment of synaptic vesicle localization (GO:0097480) | 2.88790043 |
| 109 | synaptic vesicle transport (GO:0048489) | 2.88790043 |
| 110 | cellular sodium ion homeostasis (GO:0006883) | 2.88499384 |
| 111 | negative regulation of synaptic transmission, glutamatergic (GO:0051967) | 2.88354439 |
| 112 | membrane depolarization (GO:0051899) | 2.87665350 |
| 113 | regulation of NFAT protein import into nucleus (GO:0051532) | 2.86913124 |
| 114 | regulation of synaptic transmission, dopaminergic (GO:0032225) | 2.86459119 |
| 115 | neuron recognition (GO:0008038) | 2.85756354 |
| 116 | synaptic transmission (GO:0007268) | 2.85673474 |
| 117 | neuromuscular process (GO:0050905) | 2.85593824 |
| 118 | mitotic chromosome condensation (GO:0007076) | 2.85433442 |
| 119 | regulation of amyloid precursor protein catabolic process (GO:1902991) | 2.83814197 |
| 120 | positive regulation of protein dephosphorylation (GO:0035307) | 2.82120529 |
| 121 | dopamine receptor signaling pathway (GO:0007212) | 2.81937639 |
| 122 | response to peptidoglycan (GO:0032494) | 2.81317895 |
| 123 | cellular protein complex localization (GO:0034629) | 2.73894100 |
| 124 | positive regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling | 2.65714301 |
| 125 | positive regulation of Rap GTPase activity (GO:0032854) | 2.64776230 |
| 126 | regulation of T-helper 2 cell differentiation (GO:0045628) | 2.64271790 |
| 127 | positive regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling | 2.62783582 |
| 128 | regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway | 2.62783582 |
| 129 | cortical cytoskeleton organization (GO:0030865) | 2.58981644 |
| 130 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 2.51576834 |
| 131 | glucocorticoid receptor signaling pathway (GO:0042921) | 2.50539412 |
| 132 | negative regulation of toll-like receptor signaling pathway (GO:0034122) | 2.49216029 |
| 133 | positive regulation of macrophage cytokine production (GO:0060907) | 2.46745109 |
| 134 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 2.44156673 |
| 135 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 2.44156673 |
| 136 | modulation by symbiont of host immune response (GO:0052553) | 2.44156673 |
| 137 | positive regulation by symbiont of host defense response (GO:0052509) | 2.44156673 |
| 138 | modulation by symbiont of host defense response (GO:0052031) | 2.44156673 |
| 139 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 2.44156673 |
| 140 | response to laminar fluid shear stress (GO:0034616) | 2.43818606 |
| 141 | hypotonic response (GO:0006971) | 2.43380212 |
| 142 | response to muramyl dipeptide (GO:0032495) | 2.40813629 |
| 143 | pinocytosis (GO:0006907) | 2.39500439 |
| 144 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 2.38375020 |
| 145 | negative regulation of cell killing (GO:0031342) | 2.38375020 |
| 146 | positive regulation of membrane protein ectodomain proteolysis (GO:0051044) | 2.37960115 |
| 147 | hemidesmosome assembly (GO:0031581) | 2.36435910 |
| 148 | membrane raft organization (GO:0031579) | 2.34961672 |
| 149 | maintenance of protein localization in endoplasmic reticulum (GO:0035437) | 2.34912629 |
| 150 | COPI coating of Golgi vesicle (GO:0048205) | 2.33793512 |
| 151 | Golgi transport vesicle coating (GO:0048200) | 2.33793512 |
| 152 | positive regulation of cyclin-dependent protein serine/threonine kinase activity involved in G1/S tr | 2.33394307 |
| 153 | modulation by symbiont of host cellular process (GO:0044068) | 2.32473261 |
| 154 | corticosteroid receptor signaling pathway (GO:0031958) | 2.32371651 |
| 155 | negative regulation of skeletal muscle tissue development (GO:0048642) | 2.32249924 |
| 156 | adenosine receptor signaling pathway (GO:0001973) | 2.31954546 |
| 157 | negative regulation of dendrite morphogenesis (GO:0050774) | 2.31734833 |
| 158 | macrophage activation involved in immune response (GO:0002281) | 2.31717412 |
| 159 | positive regulation of gamma-delta T cell activation (GO:0046645) | 2.28380315 |
| 160 | retrograde vesicle-mediated transport, Golgi to ER (GO:0006890) | 2.28095945 |
| 161 | potassium ion homeostasis (GO:0055075) | 2.27644119 |
| 162 | peptidyl-threonine phosphorylation (GO:0018107) | 2.27046995 |
| 163 | peptidyl-proline hydroxylation (GO:0019511) | 2.26829484 |
| 164 | peptidyl-threonine modification (GO:0018210) | 2.26055643 |
| 165 | regulation of defense response to virus by virus (GO:0050690) | 2.25390559 |
| 166 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 2.25067855 |
| 167 | positive regulation of cellular amide metabolic process (GO:0034250) | 2.24758840 |
| 168 | regulation of ARF GTPase activity (GO:0032312) | 2.22876422 |
| 169 | protein retention in ER lumen (GO:0006621) | 2.22403060 |
| 170 | regulation of macrophage cytokine production (GO:0010935) | 2.20811599 |
| 171 | regulation of epidermal growth factor-activated receptor activity (GO:0007176) | 2.19384704 |
| 172 | regulation of protein dephosphorylation (GO:0035304) | 2.19325327 |
| 173 | regulation of glucocorticoid metabolic process (GO:0031943) | 2.19100331 |
| 174 | endocytic recycling (GO:0032456) | 2.17337295 |
| 175 | positive regulation of protein export from nucleus (GO:0046827) | 2.16805992 |
| 176 | protein complex localization (GO:0031503) | 2.15538734 |
| 177 | epithelial cell differentiation involved in prostate gland development (GO:0060742) | 2.15488003 |
| 178 | actin filament bundle assembly (GO:0051017) | 2.15395689 |
| 179 | actin filament bundle organization (GO:0061572) | 2.15395689 |
| 180 | positive regulation of receptor recycling (GO:0001921) | 2.15387925 |
| 181 | regulation of Rap GTPase activity (GO:0032317) | 2.15308088 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | EZH2_22144423_ChIP-Seq_EOC_Human | 5.29188706 |
| 2 | * RARB_27405468_Chip-Seq_BRAIN_Mouse | 3.48210389 |
| 3 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 3.40175358 |
| 4 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 3.00179306 |
| 5 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 2.99539270 |
| 6 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 2.85626274 |
| 7 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 2.79117528 |
| 8 | * REST_21632747_ChIP-Seq_MESCs_Mouse | 2.77096730 |
| 9 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 2.71126937 |
| 10 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 2.62504390 |
| 11 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 2.61610191 |
| 12 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 2.61610191 |
| 13 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 2.61026478 |
| 14 | GBX2_23144817_ChIP-Seq_PC3_Human | 2.60646823 |
| 15 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 2.59203944 |
| 16 | MYC_22102868_ChIP-Seq_BL_Human | 2.53199675 |
| 17 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 2.49035179 |
| 18 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 2.48949874 |
| 19 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 2.45440920 |
| 20 | REST_18959480_ChIP-ChIP_MESCs_Mouse | 2.45392698 |
| 21 | DROSHA_22980978_ChIP-Seq_HELA_Human | 2.41755950 |
| 22 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 2.29744604 |
| 23 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 2.28529927 |
| 24 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 2.22851931 |
| 25 | LXR_22292898_ChIP-Seq_THP-1_Human | 2.20014844 |
| 26 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 2.19635128 |
| 27 | VDR_21846776_ChIP-Seq_THP-1_Human | 2.14946425 |
| 28 | TCF7_22412390_ChIP-Seq_EML_Mouse | 2.13887106 |
| 29 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 2.11931057 |
| 30 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 2.09574427 |
| 31 | CLOCK_20551151_ChIP-Seq_293T_Human | 2.06143739 |
| 32 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 2.05089009 |
| 33 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 1.98569696 |
| 34 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 1.97812145 |
| 35 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 1.92545569 |
| 36 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 1.90870725 |
| 37 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 1.88274452 |
| 38 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.85572695 |
| 39 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.84131550 |
| 40 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 1.75706270 |
| 41 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.75374240 |
| 42 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.75121094 |
| 43 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.74277955 |
| 44 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 1.69013264 |
| 45 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 1.63297336 |
| 46 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.62539308 |
| 47 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 1.59860913 |
| 48 | * RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 1.58611215 |
| 49 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.58119947 |
| 50 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.57909539 |
| 51 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.57658626 |
| 52 | P300_27058665_Chip-Seq_ZR-75-30cells_Human | 1.55599658 |
| 53 | ZFP281_18757296_ChIP-ChIP_E14_Mouse | 1.55248659 |
| 54 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.55113426 |
| 55 | * KDM2B_26808549_Chip-Seq_JURKAT_Human | 1.54988662 |
| 56 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.54389923 |
| 57 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 1.53978231 |
| 58 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.52788902 |
| 59 | * KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.51109173 |
| 60 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.51102034 |
| 61 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.50618258 |
| 62 | CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 1.46384745 |
| 63 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 1.46076037 |
| 64 | EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 1.45638603 |
| 65 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.45623848 |
| 66 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.45594631 |
| 67 | RCOR3_21632747_ChIP-Seq_MESCs_Mouse | 1.44060439 |
| 68 | KDM2B_26808549_Chip-Seq_K562_Human | 1.42999794 |
| 69 | * SMAD4_21799915_ChIP-Seq_A2780_Human | 1.41140985 |
| 70 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.40399701 |
| 71 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.39633648 |
| 72 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.39212829 |
| 73 | UBF1/2_26484160_Chip-Seq_HMEC-DERIVED_Human | 1.36269723 |
| 74 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 1.35532145 |
| 75 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.34891576 |
| 76 | MAF_26560356_Chip-Seq_TH1_Human | 1.34269032 |
| 77 | * TCF3_18467660_ChIP-ChIP_MESCs_Mouse | 1.34087015 |
| 78 | ATF3_27146783_Chip-Seq_COLON_Human | 1.32904606 |
| 79 | KLF4_18358816_ChIP-ChIP_MESCs_Mouse | 1.31156868 |
| 80 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.31065871 |
| 81 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 1.31010874 |
| 82 | * CREB1_20920259_ChIP-Seq_GC1-SPG_Mouse | 1.29403753 |
| 83 | * TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.28865886 |
| 84 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 1.27786569 |
| 85 | * CREB1_23762244_ChIP-Seq_HIPPOCAMPUS_Rat | 1.27094086 |
| 86 | * SOX2_21211035_ChIP-Seq_LN229_Gbm | 1.26772278 |
| 87 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.26434493 |
| 88 | GATA3_20176728_ChIP-ChIP_TSCs_Mouse | 1.24840694 |
| 89 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.24582551 |
| 90 | * TCFAP2C_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 1.23814800 |
| 91 | KLF4_18555785_ChIP-Seq_MESCs_Mouse | 1.23749930 |
| 92 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.23621093 |
| 93 | WT1_25993318_ChIP-Seq_PODOCYTE_Human | 1.22520402 |
| 94 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.21246446 |
| 95 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.20306461 |
| 96 | TP53_16413492_ChIP-PET_HCT116_Human | 1.18400406 |
| 97 | ZNF274_21170338_ChIP-Seq_K562_Hela | 1.18159342 |
| 98 | RING1B_27294783_Chip-Seq_ESCs_Mouse | 1.18103787 |
| 99 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.17729640 |
| 100 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.15712169 |
| 101 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 1.14717367 |
| 102 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 1.14457983 |
| 103 | P53_22127205_ChIP-Seq_FIBROBLAST_Human | 1.14146699 |
| 104 | * AR_19668381_ChIP-Seq_PC3_Human | 1.14002604 |
| 105 | RXR_22108803_ChIP-Seq_LS180_Human | 1.13454988 |
| 106 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 1.13021825 |
| 107 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 1.12756491 |
| 108 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 1.12735126 |
| 109 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 1.12301539 |
| 110 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 1.12301539 |
| 111 | AR_25329375_ChIP-Seq_VCAP_Human | 1.10986201 |
| 112 | ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.10321653 |
| 113 | KLF4_18264089_ChIP-ChIP_MESCs_Mouse | 1.10162185 |
| 114 | KLF2_18264089_ChIP-ChIP_MESCs_Mouse | 1.10162185 |
| 115 | KLF5_18264089_ChIP-ChIP_MESCs_Mouse | 1.10162185 |
| 116 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.10052822 |
| 117 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.09601663 |
| 118 | DACH1_20351289_ChIP-Seq_MDA-MB-231_Human | 1.07293269 |
| 119 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.07277740 |
| 120 | SPI1_23127762_ChIP-Seq_K562_Human | 1.06467918 |
| 121 | TET1_21490601_ChIP-Seq_MESCs_Mouse | 1.05486056 |
| 122 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.05030472 |
| 123 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.04590581 |
| 124 | * IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.03959814 |
| 125 | MYBL1_21750041_ChIP-ChIP_SPERMATOCYTES_Mouse | 1.03615561 |
| 126 | UBF1/2_26484160_Chip-Seq_HMECs_Human | 1.03076802 |
| 127 | TAF15_26573619_Chip-Seq_HEK293_Human | 1.02945160 |
| 128 | * STAT3_23295773_ChIP-Seq_U87_Human | 1.02424336 |
| 129 | MAF_26560356_Chip-Seq_TH2_Human | 1.01942426 |
| 130 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.01798622 |
| 131 | ZFP281_27345836_Chip-Seq_ESCs_Mouse | 1.01620853 |
| 132 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 1.01002126 |
| 133 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 1.00201530 |
| 134 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.99988871 |
| 135 | HSF1_23293686_ChIP-Seq_STHDH_STRIATAL_Mouse | 0.99131135 |
| 136 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 0.98897617 |
| 137 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 0.98708389 |
| 138 | NCOR1_26117541_ChIP-Seq_K562_Human | 0.98704623 |
| 139 | SMC1_22415368_ChIP-Seq_MEFs_Mouse | 0.98339975 |
| 140 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 0.98095263 |
| 141 | SALL4_18804426_ChIP-ChIP_MESCs_Mouse | 0.97947020 |
| 142 | NANOG_18700969_ChIP-ChIP_MESCs_Mouse | 0.97044601 |
| 143 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 0.96786882 |
| 144 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 0.96521404 |
| 145 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 0.96479242 |
| 146 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 0.95863257 |
| 147 | SMAD3_21741376_ChIP-Seq_HESCs_Human | 0.95425244 |
| 148 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 0.94620754 |
| 149 | P300_19829295_ChIP-Seq_ESCs_Human | 0.94312730 |
| 150 | RCOR2_21632747_ChIP-Seq_MESCs_Mouse | 0.93436696 |
| 151 | MEIS1_26923725_Chip-Seq_HEMOGENIC-ENDOTHELIUM_Mouse | 0.92925893 |
| 152 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 0.92920833 |
| 153 | TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.92697633 |
| 154 | RING1B_27294783_Chip-Seq_NPCs_Mouse | 0.92525132 |
| 155 | SMAD3_21741376_ChIP-Seq_ESCs_Human | 0.92360691 |
| 156 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 0.91289648 |
| 157 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 0.90782478 |
| 158 | PRDM14_20953172_ChIP-Seq_ESCs_Human | 0.90543142 |
| 159 | YAP1_20516196_ChIP-Seq_MESCs_Mouse | 0.87937143 |
| 160 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 0.87821781 |
| 161 | KLF4_19829295_ChIP-Seq_ESCs_Human | 0.87551065 |
| 162 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.86608291 |
| 163 | GATA1_26923725_Chip-Seq_HPCs_Mouse | 0.85905353 |
| 164 | * NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 0.85362728 |
| 165 | * TOP2B_26459242_ChIP-Seq_MCF-7_Human | 0.84682385 |
| 166 | KDM2B_26808549_Chip-Seq_DND41_Human | 0.83748344 |
| 167 | SMAD3_22036565_ChIP-Seq_ESCs_Mouse | 0.83520786 |
| 168 | SMAD4_21741376_ChIP-Seq_HESCs_Human | 0.82763305 |
| 169 | ZFP281_18358816_ChIP-ChIP_MESCs_Mouse | 0.82494712 |
| 170 | JUN_21703547_ChIP-Seq_K562_Human | 0.82399668 |
| 171 | DMRT1_23473982_ChIP-Seq_TESTES_Mouse | 0.82178012 |
| 172 | CTCF_27219007_Chip-Seq_Bcells_Human | 0.81629586 |
| 173 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 0.81397584 |
| 174 | * TFAP2A_17053090_ChIP-ChIP_MCF-7_Human | 0.80552345 |
| 175 | TCF4_23295773_ChIP-Seq_U87_Human | 0.78970803 |
| 176 | * SMAD4_21741376_ChIP-Seq_EPCs_Human | 0.78389700 |
| 177 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 0.77301473 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0004859_abnormal_synaptic_plasticity | 7.53679380 |
| 2 | MP0003880_abnormal_central_pattern | 4.89918496 |
| 3 | MP0003705_abnormal_hypodermis_morpholog | 4.33035741 |
| 4 | MP0003635_abnormal_synaptic_transmissio | 4.32586074 |
| 5 | MP0004270_analgesia | 3.76965548 |
| 6 | MP0002822_catalepsy | 3.63681747 |
| 7 | MP0009745_abnormal_behavioral_response | 3.50688218 |
| 8 | MP0002063_abnormal_learning/memory/cond | 3.44708203 |
| 9 | MP0002064_seizures | 3.24362958 |
| 10 | MP0002877_abnormal_melanocyte_morpholog | 3.08386759 |
| 11 | MP0005451_abnormal_body_composition | 3.05636294 |
| 12 | MP0001968_abnormal_touch/_nociception | 2.98405820 |
| 13 | MP0009046_muscle_twitch | 2.92631200 |
| 14 | MP0003329_amyloid_beta_deposits | 2.78094664 |
| 15 | MP0002572_abnormal_emotion/affect_behav | 2.69604241 |
| 16 | MP0001501_abnormal_sleep_pattern | 2.65647549 |
| 17 | MP0002272_abnormal_nervous_system | 2.47869376 |
| 18 | MP0003566_abnormal_cell_adhesion | 2.43178595 |
| 19 | MP0002736_abnormal_nociception_after | 2.40360767 |
| 20 | MP0002734_abnormal_mechanical_nocicepti | 2.30990074 |
| 21 | MP0003300_gastrointestinal_ulcer | 2.25174144 |
| 22 | MP0001440_abnormal_grooming_behavior | 2.23757372 |
| 23 | MP0001486_abnormal_startle_reflex | 2.22367693 |
| 24 | MP0004858_abnormal_nervous_system | 2.15701141 |
| 25 | MP0001849_ear_inflammation | 2.10021067 |
| 26 | MP0008260_abnormal_autophagy | 2.06599403 |
| 27 | MP0002909_abnormal_adrenal_gland | 1.98576732 |
| 28 | * MP0003091_abnormal_cell_migration | 1.97037621 |
| 29 | MP0002733_abnormal_thermal_nociception | 1.96678180 |
| 30 | MP0005076_abnormal_cell_differentiation | 1.91446336 |
| 31 | MP0001970_abnormal_pain_threshold | 1.87801018 |
| 32 | MP0002735_abnormal_chemical_nociception | 1.86259742 |
| 33 | MP0005423_abnormal_somatic_nervous | 1.79922850 |
| 34 | MP0003436_decreased_susceptibility_to | 1.78578803 |
| 35 | MP0003828_pulmonary_edema | 1.77606322 |
| 36 | MP0004924_abnormal_behavior | 1.74662609 |
| 37 | MP0005386_behavior/neurological_phenoty | 1.74662609 |
| 38 | MP0004185_abnormal_adipocyte_glucose | 1.74403386 |
| 39 | MP0000604_amyloidosis | 1.74281182 |
| 40 | MP0003075_altered_response_to | 1.72453600 |
| 41 | MP0004947_skin_inflammation | 1.69220372 |
| 42 | MP0005409_darkened_coat_color | 1.68859745 |
| 43 | MP0004811_abnormal_neuron_physiology | 1.68816675 |
| 44 | MP0003879_abnormal_hair_cell | 1.68153416 |
| 45 | MP0002067_abnormal_sensory_capabilities | 1.66952609 |
| 46 | MP0004510_myositis | 1.65411186 |
| 47 | MP0010352_gastrointestinal_tract_polyps | 1.65256395 |
| 48 | MP0001529_abnormal_vocalization | 1.60322573 |
| 49 | MP0009840_abnormal_foam_cell | 1.60164331 |
| 50 | MP0000858_altered_metastatic_potential | 1.57064406 |
| 51 | * MP0003453_abnormal_keratinocyte_physiol | 1.55079042 |
| 52 | MP0008569_lethality_at_weaning | 1.54968093 |
| 53 | MP0005666_abnormal_adipose_tissue | 1.51673047 |
| 54 | MP0008438_abnormal_cutaneous_collagen | 1.46807022 |
| 55 | MP0000013_abnormal_adipose_tissue | 1.46403951 |
| 56 | MP0001905_abnormal_dopamine_level | 1.46344057 |
| 57 | MP0002184_abnormal_innervation | 1.42633313 |
| 58 | MP0003191_abnormal_cellular_cholesterol | 1.40107099 |
| 59 | MP0005023_abnormal_wound_healing | 1.37189561 |
| 60 | MP0004272_abnormal_basement_membrane | 1.36142477 |
| 61 | MP0000955_abnormal_spinal_cord | 1.35914211 |
| 62 | MP0005375_adipose_tissue_phenotype | 1.35116618 |
| 63 | MP0002066_abnormal_motor_capabilities/c | 1.34586712 |
| 64 | MP0002557_abnormal_social/conspecific_i | 1.34148098 |
| 65 | MP0003633_abnormal_nervous_system | 1.32767142 |
| 66 | MP0004885_abnormal_endolymph | 1.29660864 |
| 67 | MP0002998_abnormal_bone_remodeling | 1.28236912 |
| 68 | MP0009780_abnormal_chondrocyte_physiolo | 1.27880002 |
| 69 | MP0008874_decreased_physiological_sensi | 1.26878133 |
| 70 | MP0000759_abnormal_skeletal_muscle | 1.26206792 |
| 71 | MP0000733_abnormal_muscle_development | 1.24153423 |
| 72 | MP0004087_abnormal_muscle_fiber | 1.24020649 |
| 73 | MP0001502_abnormal_circadian_rhythm | 1.18125686 |
| 74 | MP0002419_abnormal_innate_immunity | 1.17278684 |
| 75 | MP0005000_abnormal_immune_tolerance | 1.16498361 |
| 76 | MP0006276_abnormal_autonomic_nervous | 1.16433939 |
| 77 | MP0003631_nervous_system_phenotype | 1.16021372 |
| 78 | * MP0005621_abnormal_cell_physiology | 1.15800812 |
| 79 | MP0002882_abnormal_neuron_morphology | 1.14975303 |
| 80 | MP0000003_abnormal_adipose_tissue | 1.12478797 |
| 81 | MP0003448_altered_tumor_morphology | 1.12270548 |
| 82 | MP0005167_abnormal_blood-brain_barrier | 1.11430898 |
| 83 | MP0001730_embryonic_growth_arrest | 1.11315780 |
| 84 | MP0000778_abnormal_nervous_system | 1.10591905 |
| 85 | MP0002837_dystrophic_cardiac_calcinosis | 1.10249015 |
| 86 | MP0008872_abnormal_physiological_respon | 1.09358463 |
| 87 | MP0003950_abnormal_plasma_membrane | 1.08102520 |
| 88 | MP0004142_abnormal_muscle_tone | 1.07398212 |
| 89 | MP0003123_paternal_imprinting | 1.07276490 |
| 90 | MP0001853_heart_inflammation | 1.06749763 |
| 91 | MP0003172_abnormal_lysosome_physiology | 1.05743805 |
| 92 | MP0000685_abnormal_immune_system | 1.05056907 |
| 93 | MP0008961_abnormal_basal_metabolism | 1.03753444 |
| 94 | MP0003690_abnormal_glial_cell | 1.02545133 |
| 95 | MP0001915_intracranial_hemorrhage | 1.01884950 |
| 96 | MP0000343_altered_response_to | 1.01047827 |
| 97 | MP0003787_abnormal_imprinting | 0.99971008 |
| 98 | MP0000678_abnormal_parathyroid_gland | 0.99428226 |
| 99 | MP0005535_abnormal_body_temperature | 0.99125482 |
| 100 | MP0002089_abnormal_postnatal_growth/wei | 0.96541596 |
| 101 | MP0000350_abnormal_cell_proliferation | 0.96478206 |
| 102 | MP0000751_myopathy | 0.96377687 |
| 103 | MP0009278_abnormal_bone_marrow | 0.96294423 |
| 104 | MP0001851_eye_inflammation | 0.93421785 |
| 105 | MP0005257_abnormal_intraocular_pressure | 0.93401770 |
| 106 | MP0005623_abnormal_meninges_morphology | 0.93315203 |
| 107 | MP0004233_abnormal_muscle_weight | 0.92788277 |
| 108 | MP0004145_abnormal_muscle_electrophysio | 0.91848330 |
| 109 | MP0003632_abnormal_nervous_system | 0.91654240 |
| 110 | MP0002090_abnormal_vision | 0.91541214 |
| 111 | MP0002152_abnormal_brain_morphology | 0.88893934 |
| 112 | MP0000920_abnormal_myelination | 0.88163730 |
| 113 | MP0010368_abnormal_lymphatic_system | 0.88033889 |
| 114 | MP0010386_abnormal_urinary_bladder | 0.87849204 |
| 115 | MP0002229_neurodegeneration | 0.87758074 |
| 116 | MP0010630_abnormal_cardiac_muscle | 0.87669129 |
| 117 | MP0005464_abnormal_platelet_physiology | 0.87553801 |
| 118 | MP0001790_abnormal_immune_system | 0.86840242 |
| 119 | MP0005387_immune_system_phenotype | 0.86840242 |
| 120 | MP0003303_peritoneal_inflammation | 0.86798452 |
| 121 | MP0005646_abnormal_pituitary_gland | 0.86360451 |
| 122 | MP0005165_increased_susceptibility_to | 0.86096525 |
| 123 | MP0002069_abnormal_eating/drinking_beha | 0.84749542 |
| 124 | MP0003634_abnormal_glial_cell | 0.84412773 |
| 125 | MP0001984_abnormal_olfaction | 0.84360448 |
| 126 | * MP0002796_impaired_skin_barrier | 0.83892206 |
| 127 | MP0002452_abnormal_antigen_presenting | 0.83814250 |
| 128 | MP0003283_abnormal_digestive_organ | 0.82255657 |
| 129 | MP0000749_muscle_degeneration | 0.82163890 |
| 130 | MP0000747_muscle_weakness | 0.81687460 |
| 131 | MP0003646_muscle_fatigue | 0.80563743 |
| 132 | MP0003763_abnormal_thymus_physiology | 0.79534554 |
| 133 | MP0005025_abnormal_response_to | 0.79273707 |
| 134 | MP0005166_decreased_susceptibility_to | 0.78254723 |
| 135 | MP0002420_abnormal_adaptive_immunity | 0.77646364 |
| 136 | MP0001819_abnormal_immune_cell | 0.76638615 |
| 137 | MP0002060_abnormal_skin_morphology | 0.75922205 |
| 138 | MP0008004_abnormal_stomach_pH | 0.75223323 |
| 139 | MP0000579_abnormal_nail_morphology | 0.75213758 |
| 140 | MP0006082_CNS_inflammation | 0.74550443 |
| 141 | MP0002723_abnormal_immune_serum | 0.74290062 |
| 142 | * MP0005384_cellular_phenotype | 0.73952474 |
| 143 | MP0003279_aneurysm | 0.73786758 |
| 144 | MP0002148_abnormal_hypersensitivity_rea | 0.73450106 |
| 145 | MP0005310_abnormal_salivary_gland | 0.73355919 |
| 146 | MP0001177_atelectasis | 0.73314769 |
| 147 | MP0000750_abnormal_muscle_regeneration | 0.70980295 |
| 148 | MP0004484_altered_response_of | 0.69860194 |
| 149 | MP0003122_maternal_imprinting | 0.66816175 |
| 150 | MP0004085_abnormal_heartbeat | 0.66414811 |
| 151 | MP0004130_abnormal_muscle_cell | 0.62977617 |
| 152 | MP0005058_abnormal_lysosome_morphology | 0.62181581 |
| 153 | MP0000569_abnormal_digit_pigmentation | 0.59333042 |
| 154 | MP0002653_abnormal_ependyma_morphology | 0.55657161 |
| 155 | MP0003183_abnormal_peptide_metabolism | 0.55283599 |
| 156 | MP0001664_abnormal_digestion | 0.54913116 |
| 157 | MP0002269_muscular_atrophy | 0.54700025 |
| 158 | MP0004036_abnormal_muscle_relaxation | 0.53090828 |
| 159 | MP0001765_abnormal_ion_homeostasis | 0.52168819 |
| 160 | MP0002332_abnormal_exercise_endurance | 0.51241557 |
| 161 | MP0004215_abnormal_myocardial_fiber | 0.50581835 |
| 162 | MP0001485_abnormal_pinna_reflex | 0.50465596 |
| 163 | MP0001348_abnormal_lacrimal_gland | 0.49883736 |
| 164 | MP0001963_abnormal_hearing_physiology | 0.49294276 |
| 165 | MP0003045_fibrosis | 0.48947166 |
| 166 | MP0005645_abnormal_hypothalamus_physiol | 0.45952524 |
| 167 | MP0004742_abnormal_vestibular_system | 0.44777527 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Focal motor seizures (HP:0011153) | 7.46481958 |
| 2 | Myokymia (HP:0002411) | 7.33048339 |
| 3 | Visual hallucinations (HP:0002367) | 5.68355832 |
| 4 | Focal seizures (HP:0007359) | 5.64495425 |
| 5 | Atonic seizures (HP:0010819) | 4.45577513 |
| 6 | Absence seizures (HP:0002121) | 4.24801923 |
| 7 | Supranuclear gaze palsy (HP:0000605) | 4.07122468 |
| 8 | Epileptic encephalopathy (HP:0200134) | 4.01962908 |
| 9 | Dialeptic seizures (HP:0011146) | 3.92467741 |
| 10 | Generalized tonic-clonic seizures (HP:0002069) | 3.90743207 |
| 11 | Action tremor (HP:0002345) | 3.89441746 |
| 12 | Cerebral inclusion bodies (HP:0100314) | 3.78507247 |
| 13 | Neurofibrillary tangles (HP:0002185) | 3.54060769 |
| 14 | Febrile seizures (HP:0002373) | 3.34901865 |
| 15 | Depression (HP:0000716) | 3.34454021 |
| 16 | Impaired vibration sensation in the lower limbs (HP:0002166) | 3.32651723 |
| 17 | Dysmetria (HP:0001310) | 3.31296939 |
| 18 | Mutism (HP:0002300) | 3.30189165 |
| 19 | Papilledema (HP:0001085) | 3.28036822 |
| 20 | Ankle clonus (HP:0011448) | 3.24720245 |
| 21 | Progressive cerebellar ataxia (HP:0002073) | 3.19659242 |
| 22 | Annular pancreas (HP:0001734) | 3.17370848 |
| 23 | Poor eye contact (HP:0000817) | 3.15112976 |
| 24 | Postural instability (HP:0002172) | 3.12731384 |
| 25 | Dysdiadochokinesis (HP:0002075) | 3.11154520 |
| 26 | Urinary bladder sphincter dysfunction (HP:0002839) | 3.08133316 |
| 27 | Abnormality of the lower motor neuron (HP:0002366) | 3.00428329 |
| 28 | Anxiety (HP:0000739) | 2.97495482 |
| 29 | Torticollis (HP:0000473) | 2.95185563 |
| 30 | Impaired social interactions (HP:0000735) | 2.91010842 |
| 31 | Abnormal social behavior (HP:0012433) | 2.91010842 |
| 32 | Amblyopia (HP:0000646) | 2.87917279 |
| 33 | Truncal ataxia (HP:0002078) | 2.81099657 |
| 34 | Obstructive sleep apnea (HP:0002870) | 2.79136675 |
| 35 | Abnormal eating behavior (HP:0100738) | 2.79071996 |
| 36 | Urinary urgency (HP:0000012) | 2.74829810 |
| 37 | Centrally nucleated skeletal muscle fibers (HP:0003687) | 2.69668751 |
| 38 | Gaze-evoked nystagmus (HP:0000640) | 2.68755781 |
| 39 | Spastic gait (HP:0002064) | 2.66887413 |
| 40 | Bradykinesia (HP:0002067) | 2.66556895 |
| 41 | Resting tremor (HP:0002322) | 2.61975275 |
| 42 | Focal dystonia (HP:0004373) | 2.61140524 |
| 43 | Rapidly progressive (HP:0003678) | 2.59875276 |
| 44 | Intention tremor (HP:0002080) | 2.58734820 |
| 45 | Axonal loss (HP:0003447) | 2.57174795 |
| 46 | Broad-based gait (HP:0002136) | 2.56082450 |
| 47 | Global brain atrophy (HP:0002283) | 2.55566434 |
| 48 | Dysmetric saccades (HP:0000641) | 2.55258298 |
| 49 | Insidious onset (HP:0003587) | 2.55160523 |
| 50 | Termporal pattern (HP:0011008) | 2.55160523 |
| 51 | Distal lower limb amyotrophy (HP:0008944) | 2.52260729 |
| 52 | Increased connective tissue (HP:0009025) | 2.47788181 |
| 53 | Ventricular fibrillation (HP:0001663) | 2.46914705 |
| 54 | Apathy (HP:0000741) | 2.46337038 |
| 55 | Neuronal loss in central nervous system (HP:0002529) | 2.45665929 |
| 56 | Progressive inability to walk (HP:0002505) | 2.45410478 |
| 57 | Hyperacusis (HP:0010780) | 2.44650782 |
| 58 | Impaired smooth pursuit (HP:0007772) | 2.44150054 |
| 59 | Abnormality of skeletal muscle fiber size (HP:0012084) | 2.43267099 |
| 60 | Insomnia (HP:0100785) | 2.42086504 |
| 61 | Stereotypic behavior (HP:0000733) | 2.40041573 |
| 62 | Protrusio acetabuli (HP:0003179) | 2.39589445 |
| 63 | Craniofacial dystonia (HP:0012179) | 2.39197966 |
| 64 | Generalized myoclonic seizures (HP:0002123) | 2.36664843 |
| 65 | Increased variability in muscle fiber diameter (HP:0003557) | 2.36488633 |
| 66 | Hemiplegia (HP:0002301) | 2.35283940 |
| 67 | Delusions (HP:0000746) | 2.32125177 |
| 68 | Hemiparesis (HP:0001269) | 2.30843518 |
| 69 | Status epilepticus (HP:0002133) | 2.29266181 |
| 70 | Scanning speech (HP:0002168) | 2.29220522 |
| 71 | Diminished motivation (HP:0000745) | 2.27497768 |
| 72 | Gastrointestinal stroma tumor (HP:0100723) | 2.27440659 |
| 73 | Abnormality of binocular vision (HP:0011514) | 2.27432709 |
| 74 | Diplopia (HP:0000651) | 2.27432709 |
| 75 | Ankyloglossia (HP:0010296) | 2.26435925 |
| 76 | Pointed chin (HP:0000307) | 2.23236378 |
| 77 | Pheochromocytoma (HP:0002666) | 2.23236363 |
| 78 | Achilles tendon contracture (HP:0001771) | 2.23176935 |
| 79 | Cerebral aneurysm (HP:0004944) | 2.20929553 |
| 80 | Distal lower limb muscle weakness (HP:0009053) | 2.19558844 |
| 81 | Lower limb muscle weakness (HP:0007340) | 2.18510920 |
| 82 | Muscle stiffness (HP:0003552) | 2.18209166 |
| 83 | Rigidity (HP:0002063) | 2.17254431 |
| 84 | Slow saccadic eye movements (HP:0000514) | 2.17228643 |
| 85 | Megalencephaly (HP:0001355) | 2.16202778 |
| 86 | Premature rupture of membranes (HP:0001788) | 2.15498718 |
| 87 | Exercise-induced myalgia (HP:0003738) | 2.13180195 |
| 88 | Hyporeflexia of lower limbs (HP:0002600) | 2.13167603 |
| 89 | Epileptiform EEG discharges (HP:0011182) | 2.12907569 |
| 90 | Upper limb amyotrophy (HP:0009129) | 2.12358015 |
| 91 | Distal upper limb amyotrophy (HP:0007149) | 2.12358015 |
| 92 | Parkinsonism with favorable response to dopaminergic medication (HP:0002548) | 2.11444723 |
| 93 | Arterial tortuosity (HP:0005116) | 2.10937884 |
| 94 | Abnormality of macrophages (HP:0004311) | 2.10797728 |
| 95 | Impaired vibratory sensation (HP:0002495) | 2.08925736 |
| 96 | Abnormality of ocular smooth pursuit (HP:0000617) | 2.06772391 |
| 97 | EEG with generalized epileptiform discharges (HP:0011198) | 2.06110422 |
| 98 | Elevated circulating parathyroid hormone (PTH) level (HP:0003165) | 2.05728949 |
| 99 | Fetal akinesia sequence (HP:0001989) | 2.05632717 |
| 100 | Cellulitis (HP:0100658) | 2.04937935 |
| 101 | Genetic anticipation (HP:0003743) | 2.04653354 |
| 102 | Lower limb asymmetry (HP:0100559) | 2.03774266 |
| 103 | Hyperventilation (HP:0002883) | 2.03065562 |
| 104 | Excessive salivation (HP:0003781) | 2.00619724 |
| 105 | Drooling (HP:0002307) | 2.00619724 |
| 106 | Psychosis (HP:0000709) | 2.00385209 |
| 107 | Abnormality of the periventricular white matter (HP:0002518) | 2.00080091 |
| 108 | Bundle branch block (HP:0011710) | 1.99109705 |
| 109 | Nuclear cataract (HP:0100018) | 1.98740970 |
| 110 | Foot dorsiflexor weakness (HP:0009027) | 1.98570768 |
| 111 | Neuroendocrine neoplasm (HP:0100634) | 1.97961521 |
| 112 | Tetraplegia (HP:0002445) | 1.97786644 |
| 113 | Abnormality of the Achilles tendon (HP:0005109) | 1.96701828 |
| 114 | Eczematoid dermatitis (HP:0000976) | 1.96157291 |
| 115 | Abnormality of oral frenula (HP:0000190) | 1.94266161 |
| 116 | Incomplete penetrance (HP:0003829) | 1.94055664 |
| 117 | Hypsarrhythmia (HP:0002521) | 1.93315178 |
| 118 | Muscle fiber cytoplasmatic inclusion bodies (HP:0100303) | 1.90029542 |
| 119 | Cholecystitis (HP:0001082) | 1.89935900 |
| 120 | Abnormal gallbladder physiology (HP:0012438) | 1.89935900 |
| 121 | Limb dystonia (HP:0002451) | 1.89463408 |
| 122 | Spinal rigidity (HP:0003306) | 1.88342209 |
| 123 | Lower limb amyotrophy (HP:0007210) | 1.88166404 |
| 124 | Clonus (HP:0002169) | 1.87841114 |
| 125 | Abnormality of the corticospinal tract (HP:0002492) | 1.87690280 |
| 126 | EMG: myopathic abnormalities (HP:0003458) | 1.87032846 |
| 127 | Neoplasm of the peripheral nervous system (HP:0100007) | 1.86633450 |
| 128 | Gait ataxia (HP:0002066) | 1.85609404 |
| 129 | Tetraparesis (HP:0002273) | 1.85041709 |
| 130 | Dementia (HP:0000726) | 1.84655009 |
| 131 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 1.84608416 |
| 132 | Abnormality of glycolipid metabolism (HP:0010969) | 1.84608416 |
| 133 | Abnormality of liposaccharide metabolism (HP:0010968) | 1.84608416 |
| 134 | Muscle fiber splitting (HP:0003555) | 1.84070035 |
| 135 | Muscle fiber inclusion bodies (HP:0100299) | 1.84044983 |
| 136 | Loss of speech (HP:0002371) | 1.83537035 |
| 137 | Vertebral compression fractures (HP:0002953) | 1.83534743 |
| 138 | Vascular tortuosity (HP:0004948) | 1.81682239 |
| 139 | Peripheral hypomyelination (HP:0007182) | 1.81638066 |
| 140 | Hyperparathyroidism (HP:0000843) | 1.80850226 |
| 141 | Nemaline bodies (HP:0003798) | 1.79182985 |
| 142 | Hypercortisolism (HP:0001578) | 1.78861453 |
| 143 | Abnormality of the salivary glands (HP:0010286) | 1.78085462 |
| 144 | Type 1 muscle fiber predominance (HP:0003803) | 1.77775123 |
| 145 | Hammertoe (HP:0001765) | 1.77253261 |
| 146 | Myocardial infarction (HP:0001658) | 1.74516466 |
| 147 | Difficulty climbing stairs (HP:0003551) | 1.74030678 |
| 148 | Distal sensory impairment (HP:0002936) | 1.73969572 |
| 149 | Polygenic inheritance (HP:0010982) | 1.73345608 |
| 150 | Atrophic scars (HP:0001075) | 1.73035230 |
| 151 | Segmental peripheral demyelination/remyelination (HP:0003481) | 1.72404099 |
| 152 | Abnormality of the foot musculature (HP:0001436) | 1.72083533 |
| 153 | Shallow orbits (HP:0000586) | 1.71744555 |
| 154 | Upper motor neuron abnormality (HP:0002127) | 1.70649444 |
| 155 | Amyloidosis (HP:0011034) | 1.67729701 |
| 156 | Difficulty running (HP:0009046) | 1.67688091 |
| 157 | Spinal cord compression (HP:0002176) | 1.67257988 |
| 158 | Decreased motor nerve conduction velocity (HP:0003431) | 1.64962464 |
| 159 | Asymmetric septal hypertrophy (HP:0001670) | 1.62840615 |
| 160 | Thin bony cortex (HP:0002753) | 1.61983825 |
| 161 | Emphysema (HP:0002097) | 1.61329375 |
| 162 | Fatigue (HP:0012378) | 1.60192098 |
| 163 | Progressive external ophthalmoplegia (HP:0000590) | 1.59705553 |
| 164 | Bowel incontinence (HP:0002607) | 1.59172005 |
| 165 | Osteolytic defects of the hand bones (HP:0009699) | 1.58892650 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | EPHA4 | 5.40052572 |
| 2 | NTRK3 | 4.60039880 |
| 3 | RIPK4 | 3.42454385 |
| 4 | * KSR2 | 3.33832352 |
| 5 | IRAK3 | 2.99288059 |
| 6 | PAK6 | 2.84398146 |
| 7 | * MAP3K9 | 2.66610078 |
| 8 | MAP3K4 | 2.62182342 |
| 9 | MINK1 | 2.60941710 |
| 10 | NTRK1 | 2.50628634 |
| 11 | DAPK2 | 2.38947522 |
| 12 | CDK12 | 2.29484638 |
| 13 | PRKD3 | 2.27723734 |
| 14 | MAP3K12 | 2.12607770 |
| 15 | EEF2K | 2.09070344 |
| 16 | CAMKK1 | 2.01798151 |
| 17 | MAP3K2 | 1.91400137 |
| 18 | MAP2K4 | 1.89980782 |
| 19 | SMG1 | 1.85494603 |
| 20 | ERN1 | 1.84991794 |
| 21 | ICK | 1.78922652 |
| 22 | LATS2 | 1.68493382 |
| 23 | TAOK1 | 1.63792811 |
| 24 | MAP3K14 | 1.59487739 |
| 25 | TTN | 1.58897586 |
| 26 | TYRO3 | 1.57044674 |
| 27 | DAPK1 | 1.53222324 |
| 28 | PLK2 | 1.53207173 |
| 29 | MAP2K7 | 1.52276059 |
| 30 | FES | 1.52126331 |
| 31 | TAOK2 | 1.51335103 |
| 32 | * CDK5 | 1.49125901 |
| 33 | BMPR2 | 1.48126810 |
| 34 | GRK5 | 1.42084044 |
| 35 | SIK1 | 1.40076093 |
| 36 | RET | 1.38564432 |
| 37 | NTRK2 | 1.35626740 |
| 38 | IRAK2 | 1.35046564 |
| 39 | PTK2B | 1.34798947 |
| 40 | PNCK | 1.34605214 |
| 41 | STK38 | 1.32839528 |
| 42 | CAMKK2 | 1.30253055 |
| 43 | STK24 | 1.26910581 |
| 44 | CDK19 | 1.26133362 |
| 45 | * KSR1 | 1.24578479 |
| 46 | NME2 | 1.16566182 |
| 47 | FGR | 1.11383938 |
| 48 | MAP3K3 | 1.10625197 |
| 49 | SIK2 | 1.07432263 |
| 50 | FGFR4 | 1.06949544 |
| 51 | CAMK2A | 1.05210685 |
| 52 | SCYL2 | 1.03756422 |
| 53 | MAP2K3 | 1.02876886 |
| 54 | MAPK12 | 1.01673282 |
| 55 | MARK1 | 1.00381726 |
| 56 | PRPF4B | 0.98915501 |
| 57 | PAK3 | 0.98232684 |
| 58 | ALK | 0.94790587 |
| 59 | PAK4 | 0.94360810 |
| 60 | PRKCG | 0.93047660 |
| 61 | CSK | 0.91760901 |
| 62 | NEK6 | 0.86976038 |
| 63 | * CDK14 | 0.85696085 |
| 64 | NEK1 | 0.85539875 |
| 65 | PRKCH | 0.84882036 |
| 66 | CAMK1 | 0.84508249 |
| 67 | STK11 | 0.83190029 |
| 68 | CDC42BPA | 0.81587635 |
| 69 | CAMK2B | 0.78102798 |
| 70 | TESK1 | 0.77924440 |
| 71 | * RAF1 | 0.77601285 |
| 72 | * CDK15 | 0.76816412 |
| 73 | * CDK18 | 0.76596462 |
| 74 | MTOR | 0.75507082 |
| 75 | IRAK4 | 0.75348723 |
| 76 | WNK1 | 0.75048920 |
| 77 | MAP3K10 | 0.74522205 |
| 78 | PKN2 | 0.73339859 |
| 79 | * PDK1 | 0.72230003 |
| 80 | TBK1 | 0.71649659 |
| 81 | LMTK2 | 0.70018793 |
| 82 | PINK1 | 0.69856403 |
| 83 | MAP3K6 | 0.69747935 |
| 84 | NEK9 | 0.69601407 |
| 85 | JAK1 | 0.69480100 |
| 86 | FER | 0.68753742 |
| 87 | MAPK11 | 0.68554234 |
| 88 | CSNK1G2 | 0.65993119 |
| 89 | * PDPK1 | 0.65961186 |
| 90 | TYK2 | 0.64469442 |
| 91 | RIPK1 | 0.64467048 |
| 92 | * MAP3K1 | 0.64010628 |
| 93 | MET | 0.63542138 |
| 94 | * CDK11A | 0.63118343 |
| 95 | ZAP70 | 0.62788641 |
| 96 | CAMK2G | 0.61981828 |
| 97 | * MAP2K1 | 0.61554123 |
| 98 | EPHB1 | 0.60244837 |
| 99 | UHMK1 | 0.60056739 |
| 100 | SGK1 | 0.59947096 |
| 101 | DMPK | 0.59575917 |
| 102 | * MAP3K8 | 0.58768146 |
| 103 | DAPK3 | 0.58717072 |
| 104 | JAK3 | 0.57980854 |
| 105 | TRIB3 | 0.56959663 |
| 106 | PRKG2 | 0.56540044 |
| 107 | SIK3 | 0.55969573 |
| 108 | SGK494 | 0.55879625 |
| 109 | SGK223 | 0.55879625 |
| 110 | CAMK2D | 0.54940057 |
| 111 | MAP4K1 | 0.54024607 |
| 112 | PDGFRB | 0.53500738 |
| 113 | CAMK1G | 0.51572576 |
| 114 | FYN | 0.51541101 |
| 115 | BMX | 0.50107866 |
| 116 | MAPK10 | 0.49885659 |
| 117 | MAPK7 | 0.49079544 |
| 118 | MARK2 | 0.49063958 |
| 119 | PTK6 | 0.48094411 |
| 120 | PAK2 | 0.47030744 |
| 121 | OXSR1 | 0.46873371 |
| 122 | NME1 | 0.46691165 |
| 123 | GRK6 | 0.46183757 |
| 124 | CDK6 | 0.45596965 |
| 125 | PTK2 | 0.45575237 |
| 126 | CDK9 | 0.45535770 |
| 127 | RPS6KA2 | 0.43876375 |
| 128 | LRRK2 | 0.43325136 |
| 129 | MAP3K5 | 0.42449362 |
| 130 | * RPS6KA3 | 0.42246770 |
| 131 | MAP3K7 | 0.41816325 |
| 132 | PRKCZ | 0.41053516 |
| 133 | DDR2 | 0.40703442 |
| 134 | MUSK | 0.39656174 |
| 135 | MAPKAPK5 | 0.39434727 |
| 136 | SGK3 | 0.39196062 |
| 137 | MAPK13 | 0.38501808 |
| 138 | PDGFRA | 0.38202707 |
| 139 | DYRK1A | 0.38191911 |
| 140 | ABL2 | 0.37658600 |
| 141 | PRKD2 | 0.34803178 |
| 142 | ROCK2 | 0.34722500 |
| 143 | MAP3K11 | 0.33490956 |
| 144 | JAK2 | 0.30838178 |
| 145 | PHKG1 | 0.30393807 |
| 146 | PHKG2 | 0.30393807 |
| 147 | BRSK1 | 0.29875224 |
| 148 | PRKCE | 0.28109430 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 3.29148747 |
| 2 | Nicotine addiction_Homo sapiens_hsa05033 | 3.04854835 |
| 3 | Olfactory transduction_Homo sapiens_hsa04740 | 2.70412441 |
| 4 | * Long-term potentiation_Homo sapiens_hsa04720 | 2.67653096 |
| 5 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 2.65528231 |
| 6 | Circadian entrainment_Homo sapiens_hsa04713 | 2.49138046 |
| 7 | Amphetamine addiction_Homo sapiens_hsa05031 | 2.48752552 |
| 8 | GABAergic synapse_Homo sapiens_hsa04727 | 2.44291961 |
| 9 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 2.42271717 |
| 10 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 2.33065067 |
| 11 | Glutamatergic synapse_Homo sapiens_hsa04724 | 2.32507452 |
| 12 | Morphine addiction_Homo sapiens_hsa05032 | 2.21879983 |
| 13 | Dopaminergic synapse_Homo sapiens_hsa04728 | 2.13380766 |
| 14 | Salivary secretion_Homo sapiens_hsa04970 | 2.09338952 |
| 15 | Gastric acid secretion_Homo sapiens_hsa04971 | 1.87035439 |
| 16 | Insulin secretion_Homo sapiens_hsa04911 | 1.81160789 |
| 17 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 1.77164743 |
| 18 | * Cholinergic synapse_Homo sapiens_hsa04725 | 1.76168658 |
| 19 | * Oxytocin signaling pathway_Homo sapiens_hsa04921 | 1.72435674 |
| 20 | Cocaine addiction_Homo sapiens_hsa05030 | 1.66874934 |
| 21 | * GnRH signaling pathway_Homo sapiens_hsa04912 | 1.66478707 |
| 22 | Renin secretion_Homo sapiens_hsa04924 | 1.64730928 |
| 23 | * B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.64361172 |
| 24 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 1.64087651 |
| 25 | * Long-term depression_Homo sapiens_hsa04730 | 1.63166758 |
| 26 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 1.52265284 |
| 27 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 1.46307597 |
| 28 | Calcium signaling pathway_Homo sapiens_hsa04020 | 1.46198220 |
| 29 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 1.41251283 |
| 30 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 1.40770425 |
| 31 | * Serotonergic synapse_Homo sapiens_hsa04726 | 1.38976417 |
| 32 | Nitrogen metabolism_Homo sapiens_hsa00910 | 1.37798415 |
| 33 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 1.34771731 |
| 34 | * Chronic myeloid leukemia_Homo sapiens_hsa05220 | 1.34139847 |
| 35 | Taste transduction_Homo sapiens_hsa04742 | 1.29120208 |
| 36 | * Osteoclast differentiation_Homo sapiens_hsa04380 | 1.28802660 |
| 37 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 1.26440590 |
| 38 | * Gap junction_Homo sapiens_hsa04540 | 1.25829137 |
| 39 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 1.21473568 |
| 40 | * Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.20969519 |
| 41 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 1.20920846 |
| 42 | * Estrogen signaling pathway_Homo sapiens_hsa04915 | 1.18544714 |
| 43 | Amoebiasis_Homo sapiens_hsa05146 | 1.18354680 |
| 44 | * Glioma_Homo sapiens_hsa05214 | 1.17586010 |
| 45 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 1.16213282 |
| 46 | * cAMP signaling pathway_Homo sapiens_hsa04024 | 1.14072022 |
| 47 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 1.12357940 |
| 48 | * Oocyte meiosis_Homo sapiens_hsa04114 | 1.06925411 |
| 49 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.06454480 |
| 50 | Leishmaniasis_Homo sapiens_hsa05140 | 1.04003735 |
| 51 | * Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.03756930 |
| 52 | * Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 1.00816075 |
| 53 | * Pancreatic cancer_Homo sapiens_hsa05212 | 0.99701168 |
| 54 | Adherens junction_Homo sapiens_hsa04520 | 0.97484594 |
| 55 | * Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.97174335 |
| 56 | * ErbB signaling pathway_Homo sapiens_hsa04012 | 0.95338679 |
| 57 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.94902608 |
| 58 | * Focal adhesion_Homo sapiens_hsa04510 | 0.94845920 |
| 59 | * VEGF signaling pathway_Homo sapiens_hsa04370 | 0.93794018 |
| 60 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.93781821 |
| 61 | * cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.92381684 |
| 62 | * Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.91489409 |
| 63 | * T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.90799414 |
| 64 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.90614869 |
| 65 | Other glycan degradation_Homo sapiens_hsa00511 | 0.89813428 |
| 66 | * Endometrial cancer_Homo sapiens_hsa05213 | 0.89620403 |
| 67 | * Melanogenesis_Homo sapiens_hsa04916 | 0.88203073 |
| 68 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 0.88190267 |
| 69 | * Bladder cancer_Homo sapiens_hsa05219 | 0.88148381 |
| 70 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.84626008 |
| 71 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 0.84618647 |
| 72 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.84119261 |
| 73 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.81186759 |
| 74 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.80139423 |
| 75 | * Hepatitis B_Homo sapiens_hsa05161 | 0.80069389 |
| 76 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.79133328 |
| 77 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.79080552 |
| 78 | * Thyroid cancer_Homo sapiens_hsa05216 | 0.79034678 |
| 79 | * Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.78151901 |
| 80 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.78126399 |
| 81 | * Influenza A_Homo sapiens_hsa05164 | 0.77582973 |
| 82 | * TNF signaling pathway_Homo sapiens_hsa04668 | 0.76887325 |
| 83 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.76871874 |
| 84 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.76071424 |
| 85 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.74589843 |
| 86 | * Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.74473589 |
| 87 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.74388580 |
| 88 | * MAPK signaling pathway_Homo sapiens_hsa04010 | 0.73253768 |
| 89 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.72309819 |
| 90 | Endocytosis_Homo sapiens_hsa04144 | 0.72139370 |
| 91 | * Apoptosis_Homo sapiens_hsa04210 | 0.71197047 |
| 92 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.71018591 |
| 93 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 0.68519709 |
| 94 | * Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.67568064 |
| 95 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.67278027 |
| 96 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.66209835 |
| 97 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.64121892 |
| 98 | Hepatitis C_Homo sapiens_hsa05160 | 0.63916006 |
| 99 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.63790852 |
| 100 | * Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.63302868 |
| 101 | Axon guidance_Homo sapiens_hsa04360 | 0.63267392 |
| 102 | Pertussis_Homo sapiens_hsa05133 | 0.62975063 |
| 103 | * Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.62085196 |
| 104 | * Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.61634693 |
| 105 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.60776280 |
| 106 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.60320853 |
| 107 | Legionellosis_Homo sapiens_hsa05134 | 0.60251484 |
| 108 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.59652348 |
| 109 | HTLV-I infection_Homo sapiens_hsa05166 | 0.59502466 |
| 110 | Measles_Homo sapiens_hsa05162 | 0.59374825 |
| 111 | Phagosome_Homo sapiens_hsa04145 | 0.59150115 |
| 112 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.59137012 |
| 113 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.58961852 |
| 114 | * MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.58626913 |
| 115 | Malaria_Homo sapiens_hsa05144 | 0.58553104 |
| 116 | * Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.56588669 |
| 117 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.55804105 |
| 118 | * Ras signaling pathway_Homo sapiens_hsa04014 | 0.55355274 |
| 119 | * Renal cell carcinoma_Homo sapiens_hsa05211 | 0.54046799 |
| 120 | * Prion diseases_Homo sapiens_hsa05020 | 0.53911310 |
| 121 | * Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.53030845 |
| 122 | * Progesterone-mediated oocyte maturation_Homo sapiens_hsa04914 | 0.49726000 |
| 123 | * Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.47161942 |
| 124 | * Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.45876191 |
| 125 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.44705834 |
| 126 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.44576307 |
| 127 | Circadian rhythm_Homo sapiens_hsa04710 | 0.44565698 |
| 128 | Bile secretion_Homo sapiens_hsa04976 | 0.44192126 |
| 129 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.42790050 |
| 130 | Salmonella infection_Homo sapiens_hsa05132 | 0.42226642 |
| 131 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.42037381 |
| 132 | Shigellosis_Homo sapiens_hsa05131 | 0.39948485 |
| 133 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.39455988 |
| 134 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.39353885 |
| 135 | Platelet activation_Homo sapiens_hsa04611 | 0.38233676 |
| 136 | Tuberculosis_Homo sapiens_hsa05152 | 0.36982694 |
| 137 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.36511786 |
| 138 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.35175629 |
| 139 | * Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.34455575 |
| 140 | * HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.33728355 |
| 141 | * Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.32686171 |
| 142 | Lysosome_Homo sapiens_hsa04142 | 0.32681589 |
| 143 | * Insulin signaling pathway_Homo sapiens_hsa04910 | 0.32677487 |
| 144 | * Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.30764462 |

